There is no website visitor data available for this stock.
---
PMN FAQ
What was ProMIS Neurosciences’s price range in the past 12 months?
ProMIS Neurosciences lowest stock price was $0.95 and its highest was $8.95 in the past 12 months.
What is ProMIS Neurosciences’s market cap?
Currently, no data Available
When is ProMIS Neurosciences’s upcoming earnings report date?
ProMIS Neurosciences’s upcoming earnings report date is May 14, 2024 which is in 25 days.
How were ProMIS Neurosciences’s earnings last quarter?
ProMIS Neurosciences released its earnings results on Apr 01, 2024. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.165 by $0.135.
ProMIS Neurosciences does not currently pay dividends.
What is ProMIS Neurosciences’s EPS estimate?
ProMIS Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ProMIS Neurosciences have?
ProMIS Neurosciences has 18,961,117 shares outstanding.
What happened to ProMIS Neurosciences’s price movement after its last earnings report?
ProMIS Neurosciences reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.165. Following the earnings report the stock price went up 10.244%.
Which hedge fund is a major shareholder of ProMIS Neurosciences?
Currently, no hedge funds are holding shares in PMN
ProMIS Neurosciences Inc is a biotech company. It is engaged in discovering and developing precision medicine therapeutics for the effective treatment of neurodegenerative diseases, in particular, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD).
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +47.65% per trade.